Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment

This study has been completed.
Sponsor:
Information provided by:
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT00319813
First received: April 20, 2006
Last updated: April 15, 2008
Last verified: April 2008
  Purpose

A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment


Condition Intervention Phase
Pulmonary Disease, Chronic Obstructive
Behavioral: Education
Phase 4

Study Type: Observational
Official Title: General Practice Quality Assurance Project. COPD Diagnosis and Treatment

Resource links provided by NLM:


Further study details as provided by Boehringer Ingelheim:

Primary Outcome Measures:
  • To optimise the diagnosis and treatment of COPD via a quality assurance project
  • Increase the knowledge and use of diagnostic tools and treatment amongst PCPs
  • To focus on implementation of national guidelines for diagnosis and treatment of COPD

Estimated Enrollment: 8000
Estimated Study Completion Date: September 2007
  Eligibility

Ages Eligible for Study:   35 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD patients over 35 years of age
  • More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these

Exclusion Criteria:

  • Asthma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00319813

Sponsors and Collaborators
Boehringer Ingelheim
Investigators
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00319813     History of Changes
Obsolete Identifiers: NCT00479869
Other Study ID Numbers: 205.376
Study First Received: April 20, 2006
Last Updated: April 15, 2008
Health Authority: Denmark: Danish Dataprotection Agency

Additional relevant MeSH terms:
Chronic Disease
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Disease Attributes
Pathologic Processes
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on November 25, 2014